Page last updated: 2024-08-23

bezafibrate and Jaundice, Obstructive

bezafibrate has been researched along with Jaundice, Obstructive in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Enjoji, M; Fujino, T; Harada, N; Higuchi, N; Kato, M; Kohjima, M; Kotoh, K; Machida, K; Maehara, Y; Matsunaga, K; Nakamuta, M; Nakashima, M; Nishinakagawa, T; Taketomi, A; Yada, M; Yada, R; Yasutake, K; Yoshimoto, T	1

Trials

1 trial(s) available for bezafibrate and Jaundice, Obstructive

Article	Year
Therapeutic effect of bezafibrate against biliary damage: a study of phospholipid secretion via the PPARalpha-MDR3 pathway. International journal of clinical pharmacology and therapeutics, 2010, Volume: 48, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; ATP Binding Cassette Transporter, Subfamily B; Bezafibrate; Cholestasis; Drainage; Fatty Liver; Female; gamma-Glutamyltransferase; Humans; Hypolipidemic Agents; Jaundice, Obstructive; Liver Cirrhosis, Biliary; Male; Middle Aged; Phospholipids; Polymerase Chain Reaction; PPAR alpha	2010

Article

Year

Therapeutic effect of bezafibrate against biliary damage: a study of phospholipid secretion via the PPARalpha-MDR3 pathway.

International journal of clinical pharmacology and therapeutics, 2010, Volume: 48, Issue:1

Topics: Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; ATP Binding Cassette Transporter, Subfamily B; Bezafibrate; Cholestasis; Drainage; Fatty Liver; Female; gamma-Glutamyltransferase; Humans; Hypolipidemic Agents; Jaundice, Obstructive; Liver Cirrhosis, Biliary; Male; Middle Aged; Phospholipids; Polymerase Chain Reaction; PPAR alpha

2010